Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000318306-14-000009
Filing Date
2014-04-04
Accepted
2014-04-04 17:02:13
Documents
1
Period of Report
2014-04-04

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY proxy040414.htm PRE 14A 428789
  Complete submission text file 0000318306-14-000009.txt   430002
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1025
Type: PRE 14A | Act: 34 | File No.: 001-15771 | Film No.: 14746640
SIC: 2834 Pharmaceutical Preparations